tiprankstipranks
Trending News
More News >
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market

Diamedica Therapeutics (DMAC) Cash flow

Compare
555 Followers

Diamedica Therapeutics Cash Flow

DMAC's free cash flow for Q3 2025 was $-6.62M. For the 2025 fiscal year, DMAC's free cash flow was decreased by $-3.35M and operating cash flow was $-6.60M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -22.08M$ -18.73M$ -11.51M$ -12.25M$ -9.19M
Investing Cash Flow
$ 8.56M$ -18.30M$ 11.54M$ -20.54M$ -16.13M
Financing Cash Flow
$ 11.99M$ 36.84M$ -6.00K$ 30.09M$ 28.84M
End Cash Position
$ 3.02M$ 4.54M$ 4.73M$ 4.71M$ 7.41M
Free Cash Flow
$ -22.10M$ -18.75M$ -11.59M$ -12.27M$ -9.23M
Currency in USD

Diamedica Therapeutics Cash Flow